Zobrazeno 1 - 10
of 899
pro vyhledávání: '"Piotr Rutkowski"'
Autor:
Natalia Niedzbała, Ewa Lorenc-Grabowska, Piotr Rutkowski, Jacek Chęcmanowski, Anna Szymczycha-Madeja, Maja Wełna, Izabela Michalak
Publikováno v:
Bioresources and Bioprocessing, Vol 11, Iss 1, Pp 1-24 (2024)
Abstract In this work, the properties of biochar produced from green macroalga Ulva intestinalis by pyrolysis were studied at temperatures of 300, 500, and 700 °C. This biochar was characterized in terms of multielemental composition, BET surface ar
Externí odkaz:
https://doaj.org/article/2c83258fbad24bef825f7329af0e9785
Autor:
Kamil J. Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Damiano Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Rutkowski, Yacoub A. Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michal Fiedorowicz, Anna M. Czarnecka
Publikováno v:
Current Oncology, Vol 31, Iss 2, Pp 778-800 (2024)
Molecular biology studies of uveal melanoma have resulted in the development of novel immunotherapy approaches including tebentafusp—a T cell–redirecting bispecific fusion protein. More biomarkers are currently being studied. As a result, combine
Externí odkaz:
https://doaj.org/article/960539c0f6e54130a155e5bda2dce710
Autor:
Paolo A. Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Virginia Ferraresi, Ana Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbe, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F. Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero, Antonio M. Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract No prospective data were available prior to 2021 to inform selection between combination BRAF and MEK inhibition versus dual blockade of programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte antigen-4 (CTLA-4) as first-line treat
Externí odkaz:
https://doaj.org/article/2b98c18ea9d84e45baec87cc1752497f
Autor:
Paulina Chmiel, Maria Krotewicz, Anna Szumera-Ciećkiewicz, Ewa Bartnik, Anna M. Czarnecka, Piotr Rutkowski
Publikováno v:
Current Oncology, Vol 31, Iss 1, Pp 307-323 (2024)
Soft tissue sarcomas (STS) originating from connective tissue rarely affect the lymph nodes. However, involvement of lymph nodes in STS is an important aspect of prognosis and treatment. Currently, there is no consensus on the diagnosis and managemen
Externí odkaz:
https://doaj.org/article/31600efdc8274a86803e7cc96918616e
Autor:
Dirk Schadendorf, Caroline Robert, Reinhard Dummer, Luis de la Cruz-Merino, Paolo A Ascierto, John M Kirkwood, Georgina V Long, Jacek Mackiewicz, Richard A Scolyer, Piotr Rutkowski, Jean-Jacques Grob, Jason John Luke, Michele Del Vecchio, Mizuho Kalabis, Adnan Khattak, Matteo S Carlino, Yujie Zhao, Alexander Eggermont, Vanna Chiarion Sileni, Clemens Krepler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 3 (2024)
Background Adjuvant pembrolizumab significantly improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) versus placebo in the phase 3 KEYNOTE-716 study of resected stage IIB or IIC melanoma. At the prespecified third inter
Externí odkaz:
https://doaj.org/article/3a3ddc48ec6449b2b77882fcccc4b11b
Autor:
Maria Kulecka, Paweł Czarnowski, Aneta Bałabas, Maryla Turkot, Kamila Kruczkowska-Tarantowicz, Natalia Żeber-Lubecka, Michalina Dąbrowska, Ewa Paszkiewicz-Kozik, Jan Walewski, Iwona Ługowska, Hanna Koseła-Paterczyk, Piotr Rutkowski, Anna Kluska, Magdalena Piątkowska, Agnieszka Jagiełło-Gruszfeld, Michał Tenderenda, Cieszymierz Gawiński, Lucjan Wyrwicz, Magdalena Borucka, Maciej Krzakowski, Leszek Zając, Michał Kamiński, Michał Mikula, Jerzy Ostrowski
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8026 (2024)
The key association between gut dysbiosis and cancer is already known. Here, we used whole-genome shotgun sequencing (WGS) and gas chromatography/mass spectrometry (GC/MS) to conduct metagenomic and metabolomic analyses to identify common and distinc
Externí odkaz:
https://doaj.org/article/30b6864b982d48a4bee47b7dc00ebf5c
Autor:
Anna Płatkowska, Monika Słowińska, Joanna Zalewska, Zbigniew Swacha, Anna Szumera-Ciećkiewicz, Michał Wągrodzki, Janusz Patera, Katarzyna Łapieńska-Rey, Małgorzata Lorent, Iwona Ługowska, Piotr Rutkowski, Witold Owczarek
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 15, p 4377 (2024)
Background: Non-melanocytic benign skin tumours encompass a diverse group of lesions, classified based on their cellular origin, such as epidermal, vascular, fibrous, neural, muscle, and adnexal tumours. Though they often reveal solitary lesions, mul
Externí odkaz:
https://doaj.org/article/b6acbfe51b0243a7b61c5a9f0afdaa0a
Autor:
Marcin Zdzienicki, Marcin Ziętek, Maria Krotewicz, Agnieszka Ewert-Krzemieniewska, Piotr Rutkowski
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 13, p 3705 (2024)
Background/Objectives: Despite observing progress in recent years in the treatment of patients with advanced melanoma, the optimal management of locoregional recurrence has not been determined. Various methods are used to treat this group of patients
Externí odkaz:
https://doaj.org/article/a5b563a398464637a127d2fe89446055
Autor:
Caroline Robert, Ivan Marquez-Rodas, Michele Maio, Vanna Chiarion-Sileni, Piotr Rutkowski, Hans Van Eenennaam, Julien Villaudy, Jessica Kundapur, Ana Maria Arance, Alexander Eggermont, Guillemo De Velasco Oria de Rueda, Laura Lassouw-Polman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f9ea6719961d432b9f55dceb25823da4
Autor:
Piotr J. Błoński, Anna M. Czarnecka, Krzysztof Ostaszewski, Anna Szumera-Ciećkiewicz, Piotr Rutkowski
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 669 (2024)
Neoadjuvant systemic therapy is emerging as the best medical practice in patients with resectable stage III melanoma. As different regimens are expected to become available in this approach, the improved optimization of treatment strategies is requir
Externí odkaz:
https://doaj.org/article/f0064498af39477b99261bc91bf84ded